Market Research Logo

U.S. Medical Marijuana Market Size By Application (Pain Management, Muscle Spasms, Nausea, Anorexia, Seizures, Others), By Route of Administration (Inhalation, Oral, Topical), By Distribution Channel (Dispensaries, Online), Industry Analysis Report, Regio

U.S. Medical Marijuana Market Size By Application (Pain Management, Muscle Spasms, Nausea, Anorexia, Seizures, Others), By Route of Administration (Inhalation, Oral, Topical), By Distribution Channel (Dispensaries, Online), Industry Analysis Report, Regional Outlook (North East {Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, Pennsylvania}, East North Central {Illinois, Michigan}, South Atlantic {Delaware, Florida, Maryland, Washington, D.C.}, West North Central {Minnesota}, Pacific Central {Alaska, California, Hawaii, Oregon, Washington}, Mountain States {Arizona, Colorado, Nevada, New Mexico, Montana}), Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 - 2024

U.S. Medical Marijuana Market will exceed USD 8.0 billion by 2024; as per a new research report.

More than half of the U.S. states and Washington D.C. have legalized marijuana for therapeutic application. Increased number of people affected with chronic pain caused due to cancer, HIV/AIDS and neurological diseases will drive the market growth in the U.S. In addition, rigorous research and development on marijuana is also rising in the U.S., thereby opening avenues for novel products in the market.

U.S. has allowed to issue medical marijuana cards in 30 states that will enable a patient with a doctor's recommendation to obtain and possess marijuana for therapeutic use. There has been increase in the number of doctors in the U.S. recommending medical marijuana to patients as a part of their overall plan of treatment due to marijuana’s greater efficacy and usefulness, thereby boosting sales.

However, factors such as few adverse side effects of marijuana, lack of safety data, strict U.S. regulatory norms and difficulty in setting up marijuana business will act as major barriers in the growth of U.S. medical marijuana market.

The U.S. medical marijuana anorexia market segment is estimated to witness a CAGR of around 13.1% during the forecast period. Marijuana contains appetite stimulant, which accelerates the treatment of anorexia. In addition, anorexia is a serious, potentially life-threatening eating disorder in the U.S. that has been constantly increasing, thereby boosting the market segment growth.

The U.S. medical marijuana inhalation market segment is estimated to grow at 13.4% CAGR during the forecast period. Factors such as controlled dosage rates and better absorption of medical marijuana into the body will drive the inhalation route of administration market segment. Moreover, the U.S. population prefers to inhale medical marijuana owing to its better perceiving rate with high peak concentrations.

U.S. online medical marijuana market segment is forecasted to expand at a CAGR of 13.9% during 2018-2024. Factors such as vast product portfolio, convenience, and competitive costs will boost the growth of online medical marijuana market segment. Also, online distribution channel has an effective customer service that will propel the market revenue of this segment.

The U.S. Pacific Central medical marijuana market was valued at around USD 2,085.9 million in 2017. California was the first state to legalize medical marijuana way back in 1996. Other states such as Alaska, Oregon and Washington also headed in the same pathway and got the approval for medical marijuana use in 1998. All these factors are responsible for the market growth in U.S. Pacific Central.

Some of the prominent industry players in U.S. medical marijuana market are Canopy Growth, Aurora Cannabis, Inc., Medical Marijuana, Inc., GW Pharmaceuticals, Aphria, Inc., Tilray, Emerald Health Therapeutics, and United Cannabis., among others. Increasing mergers and acquisition, and rigorous research and development activities performed by these companies are resulting into new and innovative marijuana products in the U.S. market.


Data Tables
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Data Tables
2.1. U.S. Medical marijuana industry 360 degree synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Application trends
2.1.3. Route of administration trends
2.1.4. Distribution channel trends
2.1.5. Regional trends
Data Tables
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Increasing application of marijuana for a myriad of medical conditions and symptoms
3.3.1.2. Growing demand for medical marijuana legalization in the U.S.
3.3.1.3.Rising number of R&D and clinical trial activities
3.3.2. Industry pitfalls & challenges
3.3.2.1. Few side effects might hinder the market growth
3.3.2.2.Difficulty in medical marijuana business banking
3.4. Growth potential analysis
3.4.1. By application
3.4.2. By route of administration
3.4.3. By distribution channel
3.5. Porter's analysis
3.6. Competitive landscape, 2017
3.6.1. Business overview
3.6.2. Revenue analysis
3.6.3. Product landscape
3.6.4. Strategy dashboard
3.7. PESTEL analysis
3.8. Value chain analysis
3.9. Legal Requirement for Distribution of Medical Marijuana
3.10. Regulatory Landscape
Data Tables
4.1. U.S. medical marijuana market share, by application, 2017 & 2024
4.2. Pain Management
4.2.1. Market estimates and forecast, by region, 2013 - 2024
4.2.2. Neuropathic Pain
4.2.2.1. Market estimates and forecast, by region, 2013 - 2024
4.2.3. Cancer Pain
4.2.3.1. Market estimates and forecast, by region, 2013 - 2024
4.2.4. Others
4.2.4.1. Market estimates and forecast, by region, 2013 - 2024
4.3. Muscle Spasms
4.3.1. Market estimates and forecast, by region, 2013 - 2024
4.4. Nausea
4.4.1. Market estimates and forecast, by region, 2013 - 2024
4.5. Anorexia
4.5.1. Market estimates and forecast, by region, 2013 - 2024
4.6. Seizures
4.6.1. Market estimates and forecast, by region, 2013 - 2024
4.7. Others
4.7.1. Market estimates and forecast, by region, 2013 - 2024
Data Tables
5.1. U.S. medical marijuana market share, by route of administration, 2017 & 2024
5.2. Inhalation
5.2.1. Market estimates and forecast, by region, 2013 - 2024
5.3. Oral
5.3.1. Market estimates and forecast, by region, 2013 - 2024
5.4. Topical
5.4.1. Market estimates and forecast, by region, 2013 - 2024
Data Tables
6.1. Global medical marijuana market share, by distribution channel, 2017 & 2024
6.2. Dispensaries
6.2.1. Market estimates and forecast, by region, 2013 - 2024
6.3. Online
6.3.1. Market estimates and forecast, by region, 2013 - 2024
Data Tables
7.1. U.S. medical marijuana market share, by region, 2017 & 2024
7.2. North Central
7.2.1. Market estimates and forecast, by state, 2013 - 2024
7.2.2. Market estimates and forecast, by application, 2013 - 2024
7.2.2.1. Market estimates and forecast, by pain management, 2013 - 2024
7.2.3. Market estimates and forecast, by route of administration, 2013 - 2024
7.2.4. Market estimates and forecast, by distribution channel, 2013 - 2024
7.2.5. Connecticut
7.2.5.1. Market estimates and forecast, by application, 2013 - 2024
7.2.5.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.2.5.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.2.5.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.2.6.Maine
7.2.6.1. Market estimates and forecast, by application, 2013 - 2024
7.2.6.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.2.6.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.2.6.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.2.7. Massachusetts
7.2.7.1. Market estimates and forecast, by application, 2013 - 2024
7.2.7.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.2.7.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.2.7.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.2.8. New Hampshire
7.2.8.1. Market estimates and forecast, by application, 2013 - 2024
7.2.8.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.2.8.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.2.8.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.2.9.Rhode Island
7.2.9.1. Market estimates and forecast, by application, 2013 - 2024
7.2.9.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.2.9.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.2.9.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.2.10. Vermont
7.2.10.1. Market estimates and forecast, by application, 2013 - 2024
7.2.10.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.2.10.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.2.10.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.2.11. New Jersey
7.2.11.1. Market estimates and forecast, by application, 2013 - 2024
7.2.11.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.2.11.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.2.11.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.2.12. New York
7.2.12.1. Market estimates and forecast, by application, 2013 - 2024
7.2.12.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.2.12.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.2.12.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.2.13. Pennsylvania
7.2.13.1. Market estimates and forecast, by application, 2013 - 2024
7.2.13.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.2.13.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.2.13.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.3. East North Central
7.3.1. Market estimates and forecast, by state, 2013 - 2024
7.3.2. Market estimates and forecast, by application, 2013 - 2024
7.3.2.1. Market estimates and forecast, by pain management, 2013 - 2024
7.3.3. Market estimates and forecast, by route of administration, 2013 - 2024
7.3.4. Market estimates and forecast, by distribution channel, 2013 - 2024
7.3.5. Illinois
7.3.5.1. Market estimates and forecast, by application, 2013 - 2024
7.3.5.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.3.5.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.3.5.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.3.6.Michigan
7.3.6.1. Market estimates and forecast, by application, 2013 - 2024
7.3.6.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.3.6.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.3.6.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.4. South Atlantic
7.4.1. Market estimates and forecast, by state, 2013 - 2024
7.4.2. Market estimates and forecast, by application, 2013 - 2024
7.4.2.1. Market estimates and forecast, by pain management, 2013 - 2024
7.4.3. Market estimates and forecast, by route of administration, 2013 - 2024
7.4.4. Market estimates and forecast, by distribution channel, 2013 - 2024
7.4.5. Delaware
7.4.5.1. Market estimates and forecast, by application, 2013 - 2024
7.4.5.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.4.5.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.4.5.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.4.6.Florida
7.4.6.1. Market estimates and forecast, by application, 2013 - 2024
7.4.6.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.4.6.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.4.6.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.4.7. Maryland
7.4.7.1. Market estimates and forecast, by application, 2013 - 2024
7.4.7.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.4.7.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.4.7.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.4.8.Washington D.C.
7.4.8.1. Market estimates and forecast, by application, 2013 - 2024
7.4.8.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.4.8.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.4.8.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.5. West North Central
7.5.1. Market estimates and forecast, by state, 2013 - 2024
7.5.2. Market estimates and forecast, by application, 2013 - 2024
7.5.2.1. Market estimates and forecast, by pain management, 2013 - 2024
7.5.3. Market estimates and forecast, by route of administration, 2013 - 2024
7.5.4. Market estimates and forecast, by distribution channel, 2013 - 2024
7.5.5. Minnesota
7.5.5.1. Market estimates and forecast, by application, 2013 - 2024
7.5.5.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.5.5.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.5.5.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.6. Pacific Central
7.6.1. Market estimates and forecast, by state, 2013 - 2024
7.6.2. Market estimates and forecast, by application, 2013 - 2024
7.6.2.1. Market estimates and forecast, by pain management, 2013 - 2024
7.6.3. Market estimates and forecast, by route of administration, 2013 - 2024
7.6.4. Market estimates and forecast, by distribution channel, 2013 - 2024
7.6.5. Alaska
7.6.5.1. Market estimates and forecast, by application, 2013 - 2024
7.6.5.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.6.5.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.6.5.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.6.6.California
7.6.6.1. Market estimates and forecast, by application, 2013 - 2024
7.6.6.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.6.6.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.6.6.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.6.7. Hawaii
7.6.7.1. Market estimates and forecast, by application, 2013 - 2024
7.6.7.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.6.7.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.6.7.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.6.8.Oregon
7.6.8.1. Market estimates and forecast, by application, 2013 - 2024
7.6.8.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.6.8.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.6.8.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.6.9.Washington
7.6.9.1. Market estimates and forecast, by application, 2013 - 2024
7.6.9.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.6.9.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.6.9.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.7. Mountain States
7.7.1. Market estimates and forecast, by state, 2013 - 2024
7.7.2. Market estimates and forecast, by application, 2013 - 2024
7.7.2.1. Market estimates and forecast, by pain management, 2013 - 2024
7.7.3. Market estimates and forecast, by route of administration, 2013 - 2024
7.7.4. Market estimates and forecast, by distribution channel, 2013 - 2024
7.7.5. Arizona
7.7.5.1. Market estimates and forecast, by application, 2013 - 2024
7.7.5.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.7.5.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.7.5.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.7.6.Colorado
7.7.6.1. Market estimates and forecast, by application, 2013 - 2024
7.7.6.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.7.6.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.7.6.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.7.7. Nevada
7.7.7.1. Market estimates and forecast, by application, 2013 - 2024
7.7.7.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.7.7.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.7.7.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.7.8.New Mexico
7.7.8.1. Market estimates and forecast, by application, 2013 - 2024
7.7.8.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.7.8.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.7.8.3. Market estimates and forecast, by distribution channel, 2013 - 2024
7.7.9.Montana
7.7.9.1. Market estimates and forecast, by application, 2013 - 2024
7.7.9.1.1. Market estimates and forecast, by pain management, 2013 - 2024
7.7.9.2. Market estimates and forecast, by route of administration, 2013 - 2024
7.7.9.3. Market estimates and forecast, by distribution channel, 2013 - 2024
Data Tables
8.1. Canopy Growth
8.1.1.Business overview
8.1.2.Financial data
8.1.3.Product landscape
8.1.4.Strategic outlook
8.1.5.SWOT analysis
8.2. Aphria, Inc.
8.2.1.Business overview
8.2.2.Financial data
8.2.3.Product landscape
8.2.4.Strategic outlook
8.2.5.SWOT analysis
8.3. Aurora Cannabis, Inc.
8.3.1.Business overview
8.3.2.Financial data
8.3.3.Product landscape
8.3.4.Strategic outlook
8.3.5.SWOT analysis
8.4. GW Pharmaceuticals
8.4.1.Business overview
8.4.2.Financial data
8.4.3.Product landscape
8.4.4.Strategic outlook
8.4.5.SWOT analysis
8.5. mCig
8.5.1.Business overview
8.5.2.Financial data
8.5.3.Product landscape
8.5.4.Strategic outlook
8.5.5.SWOT analysis
8.6. Medical Marijuana, Inc.
8.6.1.Business overview
8.6.2.Financial data
8.6.3.Product landscape
8.6.4.Strategic outlook
8.6.5.SWOT analysis
8.7. United Cannabis
8.7.1.Business overview
8.7.2.Financial data
8.7.3.Product landscape
8.7.4.Strategic outlook
8.7.5.SWOT analysis
8.8. The Supreme Cannabis Company
8.8.1. Business overview
8.8.2. Financial data
8.8.3. Product landscape
8.8.4. Strategic outlook
8.8.5. SWOT analysis
8.9. Tilray
8.9.1. Business overview
8.9.2. Financial data
8.9.3. Product landscape
8.9.4. Strategic outlook
8.9.5. SWOT analysis
8.10. Emerald Health Therapeutics
8.10.1.Business overview
8.10.2.Financial data
8.10.3.Product landscape
8.10.4.Strategic outlook
8.10.5.SWOT analysis
8.11. Lexaria Corporation
8.11.1.Business overview
8.11.2.Financial data
8.11.3.Product landscape
8.11.4.Strategic outlook
8.11.5.SWOT analysis
8.12. Cannabis Sativa, Inc.
8.12.1.Business overview
8.12.2.Financial data
8.12.3.Product landscape
8.12.4.Strategic outlook
8.12.5.SWOT analysis
8.13. Insys Therapeutics, Inc.
8.13.1.Business overview
8.13.2.Financial data
8.13.3.Product landscape
8.13.4.Strategic outlook
8.13.5.SWOT analysis
8.14. Corbus Pharmaceuticals
8.14.1.Business overview
8.14.2.Financial data
8.14.3.Product landscape
8.14.4.Strategic outlook
8.14.5.SWOT analysis
8.15. GBSciences, Inc.
8.15.1.Business overview
8.15.2.Financial data
8.15.3.Product landscape
8.15.4.Strategic outlook
8.15.5.SWOT analysis
8.16. The Cronos Group
8.16.1.Business overview
8.16.2.Financial data
8.16.3.Product landscape
8.16.4.Strategic outlook
8.16.5.SWOT analysis
Data Tables
TABLE 1. U.S. medical marijuana industry 360 0 synopsis, 2013 - 2024
TABLE 2. U.S. medical marijuana market, 2013 - 2024, (USD Million)
TABLE 3. U.S. medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 4. U.S. medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 5. U.S. medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 6. U.S. medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 7. U.S. medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 8. U.S. medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 9. U.S. medical marijuana market by region, 2013 - 2017 (USD Million)
TABLE 10. U.S. medical marijuana market by region, 2018 - 2024 (USD Million)
TABLE 11. Industry impact forces
TABLE 12. Pain management market by region, 2013 - 2017 (USD Million)
TABLE 13. Pain management market by region, 2018 - 2024 (USD Million)
TABLE 14. Neuropathic pain market by region, 2013 - 2017 (USD Million)
TABLE 15. Neuropathic pain market by region, 2018 - 2024 (USD Million)
TABLE 16. Cancer pain market by region, 2013 - 2017 (USD Million)
TABLE 17. Cancer pain market by region, 2018 - 2024 (USD Million)
TABLE 18. Others market by region, 2013 - 2017 (USD Million)
TABLE 19. Others market by region, 2018 - 2024 (USD Million)
TABLE 20. Muscle spasms market by region, 2013 - 2017 (USD Million)
TABLE 21. Muscle spasms market by region, 2018 - 2024 (USD Million)
TABLE 22. Nausea market by region, 2013 - 2017 (USD Million)
TABLE 23. Nausea market by region, 2013 - 2017 (USD Million)
TABLE 24. Anorexia market by region, 2013 - 2017 (USD Million)
TABLE 25. Anorexia market by region, 2018 - 2024 (USD Million)
TABLE 26. Seizures market by region, 2013 - 2017 (USD Million)
TABLE 27. Seizures market by region, 2018 - 2024 (USD Million)
TABLE 28. Others market by region, 2013 - 2017 (USD Million)
TABLE 29. Others market by region, 2018 - 2024 (USD Million)
TABLE 30. Inhalation market by region, 2013 - 2017 (USD Million)
TABLE 31. Inhalation market by region, 2018 - 2024 (USD Million)
TABLE 32. Oral market by region, 2013 - 2017 (USD Million)
TABLE 33. Oral market by region, 2018 - 2024 (USD Million)
TABLE 34. Topical market by region, 2013 - 2017 (USD Million)
TABLE 35. Topical market by region, 2018 - 2024 (USD Million)
TABLE 36. Dispensaries market by region, 2013 - 2017 (USD Million)
TABLE 37. Dispensaries market by region, 2018 - 2024 (USD Million)
TABLE 38. Online market by region, 2013 - 2017 (USD Million)
TABLE 39. Online market by region, 2018 - 2024 (USD Million)
TABLE 40. East North Central medical marijuana market, by state, 2013 - 2017, (USD Million)
TABLE 41. East North Central medical marijuana market, by state, 2018 - 2024 (USD Million)
TABLE 42. East North Central medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 43. East North Central medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 44. East North Central medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 45. East North Central medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 46. East North Central medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 47. East North Central medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 48. Connecticut medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 49. Connecticut medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 50. Connecticut medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 51. Connecticut medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 52. Connecticut medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 53. Connecticut medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 54. Maine medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 55. Maine medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 56. Maine medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 57. Maine medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 58. Maine medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 59. Maine medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 60. Massachusetts medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 61. Massachusetts medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 62. Massachusetts medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 63. Massachusetts medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 64. Massachusetts medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 65. Massachusetts medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 66. New Hampshire medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 67. New Hampshire medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 68. New Hampshire medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 69. New Hampshire medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 70. New Hampshire medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 71. New Hampshire medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 72. Rhode Island medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 73. Rhode Island medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 74. Rhode Island medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 75. Rhode Island medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 76. Rhode Island medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 77. Rhode Island medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 78. Vermont medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 79. Vermont medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 80. Vermont medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 81. Vermont medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 82. Vermont medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 83. Vermont medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 84. New Jersey medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 85. New Jersey medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 86. New Jersey medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 87. New Jersey medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 88. New Jersey medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 89. New Jersey medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 90. New York medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 91. New York medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 92. New York medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 93. New York medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 94. New York medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 95. New York medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 96. Pennsylvania medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 97. Pennsylvania medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 98. Pennsylvania medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 99. Pennsylvania medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 100. Pennsylvania medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 101. Pennsylvania medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 102. East North Central medical marijuana market, by state, 2013 - 2017, (USD Million)
TABLE 103. East North Central medical marijuana market, by state, 2018 - 2024 (USD Million)
TABLE 104. East North Central medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 105. East North Central medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 106. East North Central medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 107. East North Central medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 108. East North Central medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 109. East North Central medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 110. Illinois medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 111. Illinois medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 112. Illinois medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 113. Illinois medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 114. Illinois medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 115. Illinois medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 116. Michigan medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 117. Michigan medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 118. Michigan medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 119. Michigan medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 120. Michigan medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 121. Michigan medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 122. South Atlantic medical marijuana market, by state, 2013 - 2017, (USD Million)
TABLE 123. South Atlantic medical marijuana market, by state, 2018 - 2024 (USD Million)
TABLE 124. South Atlantic medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 125. South Atlantic medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 126. South Atlantic medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 127. South Atlantic medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 128. South Atlantic medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 129. South Atlantic medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 130. Delaware medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 131. Delaware medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 132. Delaware medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 133. Delaware medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 134. Delaware medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 135. Delaware medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 136. Florida medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 137. Florida medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 138. Florida medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 139. Florida medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 140. Florida medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 141. Florida medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 142. Maryland medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 143. Maryland medical marijuana market, by application, 2018 - 2024 (USD Million)
TABLE 144. Maryland medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
TABLE 145. Maryland medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
TABLE 146. Maryland medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
TABLE 147. Maryland medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
TABLE 148. Washington D.C. medical marijuana market, by application, 2013 - 2017, (USD Million)
TABLE 149. Washington D.C. medical marijuana market, by application, 2018 - 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook